当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第24期
编号:11667399
胃癌患者血清MMP-3水平的临床研究(2)
http://www.100md.com 2008年9月5日 《中国实用医药》 2008年第24期
     参考文献

    [1] Murphy G,Stanton H,Cowell S,et al.Mechanismsfor promatrix metalloproteinase activation.APMIS,1999,107(1):38-41.

    [2] Themsche CV,Potworowski EF,Pierre ST,et al.Stromelysin-1(MMP-3)is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.Biochem Biophys Res Commun,2004,315(4):884-891.

    [3] Zucker S,Vacirca J.Role of matrix metalloproteinases(MMPs)in colorectal cancer.Metastasis Rev,2004,23(1-2):101-117.

    [4] Nawrocki R,Gilles C,Polette M,et al.E-cadherin mediates MMP downregulation in highly invasive bronchial tumor cells .Am J Pathol,2003,163(2):653-661.

    [5] Monvoisin A,Bisson C,Tayeb K,et al.Involvement of matrix metalloproteinase type-3 in hepatocyte growthfactor-induced invasion of human hepatocellular carcinoma cells .Int J Cancer,2002,97(2):157-162.

    [6] Mercapide J,Lopez D,Castresana JS,et al.tromelysin-1/matrix metalloproteinase-3(MMP-3)expression accounts forinvasive properties of human astrocytoma cell lines .Int J Cancer,2003,106(5):676-182., http://www.100md.com(周文鹏 樊青霞 范魁生 王瑞林 吴金民)
上一页1 2